alexa
Reach Us +441234923305

GET THE APP

Natasha Nagrecha | OMICS International
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Natasha Nagrecha

Mylan School of Pharmacy and Graduate School of Pharmaceutical Sciences, Duquesne University, Pittsburgh, USA

Biography

Natasha is an accomplished professional with a focus on the pharmaceutical and life sciences sector. She has proven expertise in advising several Fortune 500 clients on regulatory compliance, drug development lifecycle and mechanisms and setting up program management offices for large scale implementation initiatives. She has authored papers on clinical pharmacology and has presented in prestigious international forums. A solid academic research background combined with her experience in an advisory capacity over the years has positioned her as an individual uniquely sited to thrive in any professional services environment.
Publications

The Effect of Caffeine and Choline Combinations on Short-term Visual and Auditory Memory

The purpose of this randomized control trial was to determine whether choline in combination with several doses of caffeine, could facilitate short-term visual and verbal memory and attention in adult and middle aged human subjects with normal cognitive function. The effects of several doses of caffeine in combination with choline on short-term vis... Read More»

Natasha Nagrecha, Vincent J Giannetti, Paula A Witt-Enderby, Jamie L McConaha and David A Johnson

Research Article: Clin Pharmacol Biopharm 2013, 2:112

DOI: 10.4172/2167-065X.1000112

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF

Top